ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
67,600
+600 (0.90%)
At close: Dec 29, 2025
Market Cap1.02T
Revenue (ttm)20.33B
Net Income (ttm)-7.33B
Shares Out15.62M
EPS (ttm)-669.94
PE Ration/a
Forward PE147.69
Dividendn/a
Ex-Dividend Daten/a
Volume1,313,377
Average Volume905,942
Open68,000
Previous Close67,000
Day's Range63,800 - 73,000
52-Week Range13,740 - 87,000
Betan/a
RSI52.12
Earnings DateMar 27, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.